A randomized, double-blind, noninferiority study to compare two regimens of levonorgestrel for emergency contraception in Nigeria
OA Dada, EM Godfrey, G Piaggio, H von Hertzen - Contraception, 2010 - Elsevier
BACKGROUND: Unplanned pregnancies are common in Nigeria. Much of the unplanned
pregnancies is due to low contraceptive prevalence and high contraceptive user failure …
pregnancies is due to low contraceptive prevalence and high contraceptive user failure …
Comparative evaluation of the effectiveness and safety of two regimens of levonorgestrel for emergency contraception in Nigerians
AO Arowojolu, IA Okewole, AO Adekunle - Contraception, 2002 - Elsevier
Emergency contraception was introduced in Nigeria over two decades ago, but few women
have used this method even in emergency situations because of the side effects. To find an …
have used this method even in emergency situations because of the side effects. To find an …
Assessment of two emergency contraceptive regimens in Iran: levonorgestrel versus the Yuzpe
T Farajkhoda, A Khoshbin, B Enjezab, M Bokaei… - Nigerian journal of …, 2009 - ajol.info
The purpose of this study was to compare the efficacy and tolerability of two emergency
contraception (EC) methods, levonorgestrel versus theYuzpe. In a prospective, randomized …
contraception (EC) methods, levonorgestrel versus theYuzpe. In a prospective, randomized …
[PDF][PDF] Single dose of 1.5 mg Levonorgestrel for emergency contraception
IA Okewole, AO Arowojolu - International Journal of Gynecology & …, 2005 - academia.edu
Emergency contraception can be used to avoid pregnancy when coitus occurred during the
fertile period. It is useful for young people who engage in sporadic unprotected sexual …
fertile period. It is useful for young people who engage in sporadic unprotected sexual …
[HTML][HTML] A systematic review of effectiveness and safety of different regimens of levonorgestrel oral tablets for emergency contraception
Background Unintended pregnancy is a complex phenomenon which raise to take an
emergency decision. Low contraceptive prevalence and high user failure rates are the …
emergency decision. Low contraceptive prevalence and high user failure rates are the …
Effect on pregnancy rates of the delay in the administration of levonorgestrel for emergency contraception: a combined analysis of four WHO trials
G Piaggio, N Kapp, H Von Hertzen - Contraception, 2011 - Elsevier
BACKGROUND: Levonorgestrel is an effective method for emergency contraception (EC)
and is used worldwide. Consistent with its mechanism of action in delaying ovulation, the …
and is used worldwide. Consistent with its mechanism of action in delaying ovulation, the …
A randomized trial to compare 24 h versus 12 h double dose regimen of levonorgestrel for emergency contraception
S Wai Ngai, S Fan, S Li, L Cheng, J Ding… - Human …, 2005 - academic.oup.com
Abstract BACKGROUND: Levonorgestrel (0.75 mg given for two doses 12 h apart) has been
proven to be an effective regimen for emergency contraception when the first dose is given …
proven to be an effective regimen for emergency contraception when the first dose is given …
Levonorgestrel‐only dosing strategies for emergency contraception
The United States Food and Drug Administration‐approved progestin‐only dosing strategy
for emergency contraception is levonorgestrel 0.75 mg taken as soon as possible within 72 …
for emergency contraception is levonorgestrel 0.75 mg taken as soon as possible within 72 …
Menstrual bleeding patterns following levonorgestrel emergency contraception
E Gainer, B Kenfack, E Mboudou, AS Doh, J Bouyer - Contraception, 2006 - Elsevier
PURPOSE: Multiple trials by the World Health Organization have established levonorgestrel
as the gold standard in hormonal emergency contraception (EC). However, changes in …
as the gold standard in hormonal emergency contraception (EC). However, changes in …
Levonorgestrel-only emergency contraception: real-world tolerance and efficacy
E Gainer, C Méry, A Ulmann - Contraception, 2001 - Elsevier
Levonorgestrel-only emergency contraception was introduced onto the market in France in
May 1999 on the heels of a large-scale clinical trial demonstrating its enhanced efficacy and …
May 1999 on the heels of a large-scale clinical trial demonstrating its enhanced efficacy and …